FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 100.0% | 150.0% | – | – | 26.3% | – | – | – | – | – | – | – | |
| – | -100.0% | -150.0% | – | – | -26.3% | – | – | – | – | – | – | – | |
| – | 59,450.0% | 72,550.0% | – | – | 13,763.2% | – | – | – | – | – | – | – | |
| – | 46,900.0% | 57,516.7% | – | – | 5,581.6% | – | – | – | – | – | – | – | |
| – | 106,250.0% | 129,916.7% | – | – | 19,318.4% | – | – | – | – | – | – | – | |
| – | -106,350.0% | -130,066.7% | – | – | -19,344.7% | – | – | – | – | – | – | – | |
| – | 1,700.0% | 1,700.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -97,866.7% | -123,666.7% | – | – | -18,828.9% | – | – | – | – | – | – | – | |
| – | 1,900.6% | -571.3% | – | – | 90.2% | – | – | – | – | – | – | – | |
| – | -97,866.7% | -123,666.7% | – | – | -18,828.9% | – | – | – | – | – | – | – | |
| – | -106,250.0% | -123,516.7% | – | – | -18,802.6% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.